☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
expanded use
Janssen Receives EC's Approval for Expanded Use of Erleada (apalutamide) to Treat Metastatic Hormone-Sensitive Prostate Cancer
January 30, 2020
Janssen Receives EC's Approval for the Expanded Use of Stelara (Ustekinumab) to Treat Pediatric Patients with Moderate to Severe P...
January 24, 2020
Chugai Receives MHLW's Approval for the Expanded Use of FoundationOne CDx as a Companion Diagnostic of Rozlytrek (entrectinib)
December 27, 2019
Janssen's Stelara (ustekinumab) Receives EC's Approval for its Expanded Use to Treat Moderately to Severely Active Ulcerative Coli...
September 5, 2019
Janssen's Imbruvica (ibrutinib) Receives CHMP Positive Recommendation for its Expanded Use in Chronic Lymphocytic Leukaemia and Wa...
July 1, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.